Efficacy and Safety of Concurrent Chemoradiotherapy Combined With Induction Chemotherapy or Adjuvant Chemotherapy in Patients With Stage II-IVA Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis and Meta-Analysis.

Yang, Jie; Liang, Zhong-Guo; Jiang, Yu-Ting; Chen, Kai-Hua; Li, Ling; Qu, Song; Zhu, Xiao-Dong

Yang, Jie; Liang, Zhong-Guo; Jiang, Yu-Ting; Chen, Kai-Hua; Li, Ling; Qu, Song; Zhu, Xiao-Dong.

Afiliación

Yang J; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.
Liang ZG; Department of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China.
Jiang YT; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.
Chen KH; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.
Li L; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.
Qu S; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.
Zhu XD; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.

Front Oncol ; 11: 778836, 2021.

Article en En | MEDLINE | ID: mdl-34926289

Palabras clave

adjuvant chemotherapy (AC); concurrent chemoradiotherapy (CCRT); induction chemotherapy (IC); meta-analysis; nasopharyngeal carcinoma; propensity score-matched analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google